SPOP and prostate carcinoma: Based upon our NMR spectroscopy and X-ray crystallography results that Geminin interacts with SPOP-MATH domain on a surface frequently mutated in prostate cancer patients (Fig. 1h–k), we examined whether prostate cancer-associated mutations in SPOP would impair its ability to promote Geminin poly-ubiquitination.